AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 10914843 — intervention group
Group type: COMPARATOR
Intervention: No prednisone
Number of subjects: 824
Study 8838183 — intervention group
Group type: EXPERIMENTAL
Intervention: Pyrimethamine-clindamycin (Pyr-Cm)
Number of subjects: 299
Study 8838183 — intervention group
Group type: COMPARATOR
Intervention: Pyrimethamine-sulfadiazine (Pyr-Sdz)
Number of subjects: 299
Study 1428189 — intervention group
Group type: EXPERIMENTAL
Intervention: Loracarbef (200 mg capsule twice daily or 15 mg/kg/day oral suspension in two divided doses up to a maximum of 375 mg/day)
Number of subjects: 344
Study 1428189 — intervention group
Group type: COMPARATOR
Intervention: Penicillin V (250 mg capsule four times daily or 20 mg/kg/day suspension in four divided doses up to a maximum of 500 mg/day)
Number of subjects: 344
Study 1428189 — intervention group
Group type: EXPERIMENTAL
Intervention: Loracarbef
Number of subjects: 344
Study 3880876 — intervention group
Group type: EXPERIMENTAL
Intervention: 150 IU of d, 1 alpha‐tocopherol per day for two months
Number of subjects: 128
Study 3880876 — intervention group
Group type: EXPERIMENTAL
Intervention: 300 IU of d, 1 alpha‐tocopherol per day for two months
Number of subjects: 128
Study 3880876 — intervention group
Group type: EXPERIMENTAL
Intervention: 600 IU of d, 1 alpha‐tocopherol per day for two months
Number of subjects: 128
Study 3880876 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 128
Study 3880876 — intervention group
Group type: EXPERIMENTAL
Intervention: Measurement of serum concentrations of estradiol, progesterone, dehydroepiandrosterone sulfate, and testosterone before and after treatment
Number of subjects: 128
Study 29520956 — intervention group
Group type: EXPERIMENTAL
Intervention: Anti-bacterial soap (NP-S)
Number of subjects: 60
Study 29520956 — intervention group
Group type: EXPERIMENTAL
Intervention: Anti-bacterial soap (P-S)
Number of subjects: 60
Study 29520956 — intervention group
Group type: COMPARATOR
Intervention: Distilled water (NP-DW)
Number of subjects: 60
Study 29520956 — intervention group
Group type: COMPARATOR
Intervention: Distilled water (P-DW)
Number of subjects: 60
Study 29520956 — intervention group
Group type: EXPERIMENTAL
Intervention: Chlorhexidine gluconate solution (2%) (NP-CHX)
Number of subjects: 60
Study 29520956 — intervention group
Group type: EXPERIMENTAL
Intervention: Chlorhexidine gluconate solution (2%) (P-CHX)
Number of subjects: 60
Study 30541621 — intervention group
Group type: EXPERIMENTAL
Intervention: Baby Steps programme (group education programme and mobile web application)
Number of subjects: 290
Study 30541621 — intervention group
Group type: EXPERIMENTAL
Intervention: Baby Steps programme
Number of subjects: 290
Study 30541621 — intervention group
Group type: COMPARATOR
Intervention: Usual care (control group)
Number of subjects: 290
Study 28078208 — intervention group
Group type: EXPERIMENTAL
Intervention: Risperidone
Number of subjects: 173
Study 28078208 — intervention group
Group type: EXPERIMENTAL
Intervention: Olanzapine
Number of subjects: 173
Study 28078208 — intervention group
Group type: EXPERIMENTAL
Intervention: Quetiapine
Number of subjects: 173
Study 28078208 — intervention group
Group type: EXPERIMENTAL
Intervention: Ziprasidone
Number of subjects: 173
Study 28078208 — intervention group
Group type: EXPERIMENTAL
Intervention: ITT group analysis for Risperidone
Number of subjects: 173
Study 28078208 — intervention group
Group type: EXPERIMENTAL
Intervention: ITT group analysis for Olanzapine
Number of subjects: 173
Study 28078208 — intervention group
Group type: EXPERIMENTAL
Intervention: ITT group analysis for Quetiapine
Number of subjects: 173
Study 28078208 — intervention group
Group type: EXPERIMENTAL
Intervention: ITT group analysis for Ziprasidone
Number of subjects: 173
Study 24901365 — intervention group
Group type: EXPERIMENTAL
Intervention: Dapivirine vaginal ring (25 mg) used continuously for 28 days
Number of subjects: 16
Study 24901365 — intervention group
Group type: COMPARATOR
Intervention: Placebo vaginal ring
Number of subjects: 16
Study 24901365 — intervention group
Group type: EXPERIMENTAL
Intervention: Dapivirine vaginal ring
Number of subjects: 16
Study 21656252 — intervention group
Group type: EXPERIMENTAL
Intervention: Participatory return-to-work (RTW) program
Number of subjects: 79
Study 21190965 — intervention group
Group type: EXPERIMENTAL
Intervention: Longlasting insecticidal nets (treated with deltamethrin)
Number of subjects: 12691
Study 21190965 — intervention group
Group type: COMPARATOR
Intervention: Control (no nets)
Number of subjects: 12691
Study 19142539 — intervention group
Group type: EXPERIMENTAL
Intervention: Proposed technique (vaginoscopy using normal saline at 36 degrees C)
Number of subjects: 184
Study 19142539 — intervention group
Group type: COMPARATOR
Intervention: Traditional technique (CO2)
Number of subjects: 184
Study 19142539 — intervention group
Group type: EXPERIMENTAL
Intervention: Proposed technique
Number of subjects: 184
Study 19142539 — intervention group
Group type: COMPARATOR
Intervention: Traditional technique
Number of subjects: 184
Study 15629415 — intervention group
Group type: EXPERIMENTAL
Intervention: Oxymorphone ER (10 to 110 mg)
Number of subjects: 213
Study 15629415 — intervention group
Group type: EXPERIMENTAL
Intervention: Oxycodone CR (20 to 220 mg)
Number of subjects: 213
Study 15629415 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 213
Study 12833472 — intervention group
Group type: EXPERIMENTAL
Intervention: Darbepoetin alfa for the treatment of anemia
Number of subjects: 250
Study 12833472 — intervention group
Group type: COMPARATOR
Intervention: Placebo (control group)
Number of subjects: 250
Study 10700535 — intervention group
Group type: EXPERIMENTAL
Intervention: Rice and beans based diet for 3 consecutive days
Number of subjects: 35
Study 8428041 — intervention group
Group type: EXPERIMENTAL
Intervention: Diflorasone diacetate ointment 0.05%
Number of subjects: 44
Study 8428041 — intervention group
Group type: COMPARATOR
Intervention: Betamethasone dipropionate ointment 0.05%
Number of subjects: 44
Study 3619423 — intervention group
Group type: EXPERIMENTAL
Intervention: 200 mg intravenously
Number of subjects: 24
Study 3619423 — intervention group
Group type: EXPERIMENTAL
Intervention: 750 mg orally
Number of subjects: 24
Study 3619423 — intervention group
Group type: EXPERIMENTAL
Intervention: Both intravenous and oral administration
Number of subjects: 24
Study 29187419 — intervention group
Group type: EXPERIMENTAL
Intervention: F1 hybrids, reciprocal crosses, and parental selfs grown in randomized complete block design
Number of subjects: 6
Study 29187419 — intervention group
Group type: EXPERIMENTAL
Intervention: F1 hybrids, reciprocal crosses, and parental selfs
Number of subjects: 6
Study 27499456 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 439
Study 27499456 — intervention group
Group type: EXPERIMENTAL
Intervention: Empagliflozin 10mg
Number of subjects: 439
Study 27499456 — intervention group
Group type: EXPERIMENTAL
Intervention: Empagliflozin 25mg
Number of subjects: 439
Study 26503990 — intervention group
Group type: EXPERIMENTAL
Intervention: iPad™ intervention targeting social communication skills
Number of subjects: 54
Study 23855325 — intervention group
Group type: EXPERIMENTAL
Intervention: Appearance-change instruction (ACI)
Number of subjects: 315
Study 23855325 — intervention group
Group type: COMPARATOR
Intervention: No appearance-change instruction (Control)
Number of subjects: 315
Study 20703578 — intervention group
Group type: EXPERIMENTAL
Intervention: Artificial Neural Network (ANN) analysis using routine laboratory data (PT, INR, platelet count, direct bilirubin, AST/ALT, AST/PLT, and age)
Number of subjects: 144
Study 20703578 — intervention group
Group type: COMPARATOR
Intervention: Logistic regression model
Number of subjects: 144
Study 18823772 — intervention group
Group type: EXPERIMENTAL
Intervention: Oligonucleotide sensor using photon upconverting nanoparticles (NaYF(4) doped with Yb(3+) and Er(3+))
Number of subjects: 0
Study 18823772 — intervention group
Group type: COMPARATOR
Intervention: Conventional fluorophore, N,N,N',N'‐tetramethyl‐6‐carboxyrhodamine (TAMRA)
Number of subjects: 0
Study 17118022 — intervention group
Group type: EXPERIMENTAL
Intervention: Counting chamber method (using uncentrifuged urine)
Number of subjects: 0
Study 17118022 — intervention group
Group type: COMPARATOR
Intervention: Conventional sedimentation method
Number of subjects: 0
Study 15043296 — intervention group
Group type: EXPERIMENTAL
Intervention: Picoprep‐3
Number of subjects: 400
Study 15043296 — intervention group
Group type: COMPARATOR
Intervention: Fleet
Number of subjects: 400
Study 14639176 — intervention group
Group type: EXPERIMENTAL
Intervention: Pressure preset ventilator (PPV)
Number of subjects: 11
Study 14639176 — intervention group
Group type: COMPARATOR
Intervention: Volume preset ventilator
Number of subjects: 11
Study 12167896 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluoridated whitening dentifrice
Number of subjects: 57
Study 12167896 — intervention group
Group type: COMPARATOR
Intervention: Fluoridated regular dentifrice
Number of subjects: 57
Study 8617581 — intervention group
Group type: EXPERIMENTAL
Intervention: Didemnin B at 3.5 mg/m2
Number of subjects: 32
Study 8617581 — intervention group
Group type: EXPERIMENTAL
Intervention: Didemnin B at 6.3 mg/m2
Number of subjects: 32
Study 2666024 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral beta-carotene (50 mg/day)
Number of subjects: 1805
Study 2666024 — intervention group
Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 1805
Study 987254 — intervention group
Group type: EXPERIMENTAL
Intervention: Fusaric acid calcium salt (5.1 mg/Kg to 6.0 mg/Kg)
Number of subjects: 8
Study 987254 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 8
Study 987254 — intervention group
Group type: EXPERIMENTAL
Intervention: Fusaric acid calcium salt
Number of subjects: 8
Study 30291602 — intervention group
Group type: EXPERIMENTAL
Intervention: Automated calls coupled with phone-based pharmacist counseling
Number of subjects: 4876
Study 30291602 — intervention group
Group type: COMPARATOR
Intervention: Control clinics (propensity-matched cohort)
Number of subjects: 4876
Study 28489737 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral use of montelukast sodium
Number of subjects: 195
Study 28489737 — intervention group
Group type: EXPERIMENTAL
Intervention: Nasal spray of mometasone furoate
Number of subjects: 195
Study 28489737 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral use of montelukast sodium + nasal spray of mometasone furoate
Number of subjects: 195
Study 28489737 — intervention group
Group type: COMPARATOR
Intervention: Control group (A and B)
Number of subjects: 195
Study 25836732 — intervention group
Group type: EXPERIMENTAL
Intervention: Telepractice delivery of flow phonation voice therapy exercises
Number of subjects: 14
Study 25836732 — intervention group
Group type: COMPARATOR
Intervention: In-person delivery of flow phonation voice therapy exercises
Number of subjects: 14
Study 23095218 — intervention group
Group type: EXPERIMENTAL
Intervention: Psychometric algorithm for identifying MCI
Number of subjects: 0
Study 23095218 — intervention group
Group type: EXPERIMENTAL
Intervention: Stably impaired classification over 5 years
Number of subjects: 0
Study 23095218 — intervention group
Group type: EXPERIMENTAL
Intervention: Inconsistent classification over time
Number of subjects: 0
Study 21284444 — intervention group
Group type: EXPERIMENTAL
Intervention: Computer-aided digital microscopy
Number of subjects: 14
Study 21284444 — intervention group
Group type: COMPARATOR
Intervention: Unaided digital microscopy
Number of subjects: 14
Study 19482892 — intervention group
Group type: EXPERIMENTAL
Intervention: Botulinum toxin injection guided by electrical stimulation plus physiotherapy
Number of subjects: 65
Study 19482892 — intervention group
Group type: EXPERIMENTAL
Intervention: Botulinum toxin injection guided by palpation plus physiotherapy
Number of subjects: 65
Study 19482892 — intervention group
Group type: COMPARATOR
Intervention: Physiotherapy only
Number of subjects: 65
Study 16524346 — intervention group
Group type: EXPERIMENTAL
Intervention: Computer-assisted behavior change program
Number of subjects: 217
Study 16524346 — intervention group
Group type: COMPARATOR
Intervention: Computerized health risk assessment
Number of subjects: 217
Study 12601540 — intervention group
Group type: EXPERIMENTAL
Intervention: Chemotherapy (CT) alone
Number of subjects: 131
Study 12601540 — intervention group
Group type: EXPERIMENTAL
Intervention: Chemoradiotherapy (CTRT)
Number of subjects: 131
Study 12601540 — intervention group
Group type: COMPARATOR
Intervention: No salvage therapy (Control)
Number of subjects: 131
Study 11938859 — intervention group
Group type: EXPERIMENTAL
Intervention: Lumbricus solution applied to wound surface after hemorrhoidectomy
Number of subjects: 0
Study 11938859 — intervention group
Group type: COMPARATOR
Intervention: Lithospermum erythrorhizon medicated gauze (control)
Number of subjects: 0
Study 11938859 — intervention group
Group type: EXPERIMENTAL
Intervention: Lumbricus solution
Number of subjects: 0
Study 11938859 — intervention group
Group type: EXPERIMENTAL
Intervention: Lumbricus preparation
Number of subjects: 0
Study 9086746 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.25% KT‐210
Number of subjects: 10
Study 9086746 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study 8278826 — intervention group
Group type: EXPERIMENTAL
Intervention: 8 inch-lbs torque
Number of subjects: 102
Study 8278826 — intervention group
Group type: COMPARATOR
Intervention: 6 inch-lbs torque
Number of subjects: 102
Study 3552843 — intervention group
Group type: EXPERIMENTAL
Intervention: Streptokinase (SK)
Number of subjects: 251
Study 3552843 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 251
Study 3552843 — intervention group
Group type: EXPERIMENTAL
Intervention: Streptokinase (SK) within 3 hours
Number of subjects: 251
Study 29334925 — intervention group
Group type: EXPERIMENTAL
Intervention: Blended Learning (BL)
Number of subjects: 30
Study 29334925 — intervention group
Group type: COMPARATOR
Intervention: Face-to-Face Learning (F2FL)
Number of subjects: 30
Study 27431239 — intervention group
Group type: EXPERIMENTAL
Intervention: Multimedia intervention delivered daily from Day 1 to Day 5 via iPad™, comprising information on the goals of care for each day following surgery.
Number of subjects: 240
Study 27431239 — intervention group
Group type: COMPARATOR
Intervention: Usual care as determined by care pathways currently in use across the organization.
Number of subjects: 240
Study 23799825 — intervention group
Group type: EXPERIMENTAL
Intervention: Cold-water immersion (CWI), full-body compression garments (CG), sleep-hygiene recommendations
Number of subjects: 8
Study 23799825 — intervention group
Group type: EXPERIMENTAL
Intervention: Cold-water immersion (CWI) and full-body compression garments (CG)
Number of subjects: 8
Study 23799825 — intervention group
Group type: EXPERIMENTAL
Intervention: Sleep-hygiene recommendations
Number of subjects: 8
Study 23799825 — intervention group
Group type: COMPARATOR
Intervention: Control condition (postsession stretching, no regulation of sleeping patterns)
Number of subjects: 8
Study 22820584 — intervention group
Group type: EXPERIMENTAL
Intervention: 3D‐CRT
Number of subjects: 71
Study 22820584 — intervention group
Group type: COMPARATOR
Intervention: IMRT
Number of subjects: 71
Study 20656223 — intervention group
Group type: EXPERIMENTAL
Intervention: Plug deployed through the coaxial needle just before the needle was removed
Number of subjects: 339
Study 20656223 — intervention group
Group type: COMPARATOR
Intervention: Control (no plug)
Number of subjects: 339
Study 18318927 — intervention group
Group type: EXPERIMENTAL
Intervention: Automated telephone reminder system (ATRS)
Number of subjects: 253
Study 15790743 — intervention group
Group type: EXPERIMENTAL
Intervention: Clearfil SE Bond
Number of subjects: 24
Study 15790743 — intervention group
Group type: EXPERIMENTAL
Intervention: Clearfil Protect Bond
Number of subjects: 24
Study 15790743 — intervention group
Group type: COMPARATOR
Intervention: In vivo and in vitro conditions
Number of subjects: 24
Study 12865917 — intervention group
Group type: EXPERIMENTAL
Intervention: Stopped hormone replacement therapy (HRT)
Number of subjects: 3
Study 12865917 — intervention group
Group type: COMPARATOR
Intervention: Continued taking HRT
Number of subjects: 3
Study 12865917 — intervention group
Group type: COMPARATOR
Intervention: Not taking HRT
Number of subjects: 3
Study 10591436 — intervention group
Group type: EXPERIMENTAL
Intervention: Non-nutritive sucking (NNS) in preterm infants
Number of subjects: 0
Study 10591436 — intervention group
Group type: EXPERIMENTAL
Intervention: Non-nutritive sucking (NNS) in full-term infants
Number of subjects: 0
Study 8901801 — intervention group
Group type: EXPERIMENTAL
Intervention: Oat meal
Number of subjects: 12
Study 8901801 — intervention group
Group type: EXPERIMENTAL
Intervention: Wheat meal
Number of subjects: 12
Study 8901801 — intervention group
Group type: EXPERIMENTAL
Intervention: Corn meal
Number of subjects: 12
Study 8901801 — intervention group
Group type: COMPARATOR
Intervention: Fasting trial (Control)
Number of subjects: 12
Study 1857480 — intervention group
Group type: EXPERIMENTAL
Intervention: Desferrioxamine (DFO) at a dose of 20-30 mg/kg
Number of subjects: 17
Study 1857480 — intervention group
Group type: COMPARATOR
Intervention: Recombinant human erythropoietin (r‐HuEPO) at a dose of 40 units/kg/dialysis i.v.
Number of subjects: 17
Study 1857480 — intervention group
Group type: EXPERIMENTAL
Intervention: Desferrioxamine (DFO)
Number of subjects: 17
Study 1857480 — intervention group
Group type: COMPARATOR
Intervention: Recombinant human erythropoietin (r‐HuEPO)
Number of subjects: 17
Study 7048921 — intervention group
Group type: EXPERIMENTAL
Intervention: Acyclovir
Number of subjects: 107
Study 7048921 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 107
Study 31250239 — intervention group
Group type: EXPERIMENTAL
Intervention: Interactive ultrasounds at 24, 30, and 34 gestational weeks and a pregnancy diary with prenatal infant mental health consultations (n=46)
Number of subjects: 90
Study 31250239 — intervention group
Group type: COMPARATOR
Intervention: Treatment-as-usual (n=44)
Number of subjects: 90
Study 31250239 — intervention group
Group type: EXPERIMENTAL
Intervention: Interactive ultrasounds (n=46)
Number of subjects: 90
Study 31250239 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (n=90)
Number of subjects: 90
Study 29905904 — intervention group
Group type: EXPERIMENTAL
Intervention: Beta-alanine (6.4 g day-1)
Number of subjects: 20
Study 29905904 — intervention group
Group type: COMPARATOR
Intervention: Placebo (maltodextrin)
Number of subjects: 20
Study 28707021 — intervention group
Group type: EXPERIMENTAL
Intervention: Trendelenburg positioning before AVR
Number of subjects: 37
Study 28707021 — intervention group
Group type: EXPERIMENTAL
Intervention: Trendelenburg positioning after AVR
Number of subjects: 37
Study 26099861 — intervention group
Group type: EXPERIMENTAL
Intervention: Inhaled corticosteroids (ICS)
Number of subjects: 189
Study 24931055 — intervention group
Group type: EXPERIMENTAL
Intervention: High frequency of dietary self-monitoring
Number of subjects: 220
Study 24931055 — intervention group
Group type: EXPERIMENTAL
Intervention: High consistency of dietary self-monitoring
Number of subjects: 220
Study 24931055 — intervention group
Group type: EXPERIMENTAL
Intervention: Comprehensiveness of information recorded
Number of subjects: 220
Study 24931055 — intervention group
Group type: EXPERIMENTAL
Intervention: Adherence to daily caloric intake goals
Number of subjects: 220
Study 21373868 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 8
Study 21373868 — intervention group
Group type: EXPERIMENTAL
Intervention: Tyvek
Number of subjects: 8
Study 21373868 — intervention group
Group type: EXPERIMENTAL
Intervention: Vinyl
Number of subjects: 8
Study 21373868 — intervention group
Group type: EXPERIMENTAL
Intervention: W (p)
Number of subjects: 8
Study 19994686 — intervention group
Group type: EXPERIMENTAL
Intervention: Muscular needling combined with scarring moxibustion
Number of subjects: 60
Study 19994686 — intervention group
Group type: COMPARATOR
Intervention: Medication group (oral Diclofenac sodium and intramuscular Methotrexate)
Number of subjects: 60
Study 17466225 — intervention group
Group type: EXPERIMENTAL
Intervention: Revascularization (n = 49)
Number of subjects: 101
Study 17466225 — intervention group
Group type: COMPARATOR
Intervention: No revascularization
Number of subjects: 101
Study 14731164 — intervention group
Group type: COMPARATOR
Intervention: Ritonavir 200 mg bid
Number of subjects: 12
Study 14731164 — intervention group
Group type: EXPERIMENTAL
Intervention: Lopinavir 400 mg bid added on day 15
Number of subjects: 12
Study 11677800 — intervention group
Group type: EXPERIMENTAL
Intervention: Constant load test with individual lactate minimum intensity (CT1) at 83 +/- 32 watts for 30 minutes.
Number of subjects: 60
Study 11677800 — intervention group
Group type: COMPARATOR
Intervention: Constant load test with intensity 10% above the LMI (CT2) at 95 +/- 31 watts for 30 minutes.
Number of subjects: 60
Study 9134405 — intervention group
Group type: EXPERIMENTAL
Intervention: Surgical treatment
Number of subjects: 0
Study 9134405 — intervention group
Group type: COMPARATOR
Intervention: Medical treatment
Number of subjects: 0
Study 7963907 — intervention group
Group type: EXPERIMENTAL
Intervention: 600 mg rifampin (RMP)
Number of subjects: 29
Study 7963907 — intervention group
Group type: EXPERIMENTAL
Intervention: 1200 mg rifampin (RMP)
Number of subjects: 29
Study 7963907 — intervention group
Group type: EXPERIMENTAL
Intervention: Single dose of rifampin (RMP)
Number of subjects: 29
Study 7963907 — intervention group
Group type: EXPERIMENTAL
Intervention: Two doses of rifampin (RMP)
Number of subjects: 29
Study 3115136 — intervention group
Group type: EXPERIMENTAL
Intervention: Ro 15-1788 (1 ml = 0.1 mg active drug)
Number of subjects: 60
Study 3115136 — intervention group
Group type: COMPARATOR
Intervention: Placebo (5% glucose solution)
Number of subjects: 60
Study 31237377 — intervention group
Group type: EXPERIMENTAL
Intervention: Problem-solving intervention (n=50)
Number of subjects: 100
Study 31237377 — intervention group
Group type: COMPARATOR
Intervention: Usual care control group (n=50)
Number of subjects: 100
Study 29424802 — intervention group
Group type: EXPERIMENTAL
Intervention: Topiramate
Number of subjects: 0
Study 29424802 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 26823128 — intervention group
Group type: EXPERIMENTAL
Intervention: Caffeine (5 mg/kg) in CC trial
Number of subjects: 14
Study 26823128 — intervention group
Group type: EXPERIMENTAL
Intervention: Caffeine (5 mg/kg) in PC trial
Number of subjects: 14
Study 26823128 — intervention group
Group type: COMPARATOR
Intervention: Placebo in CP trial
Number of subjects: 14
Study 26823128 — intervention group
Group type: COMPARATOR
Intervention: Placebo in PP trial
Number of subjects: 14
Study 24724878 — intervention group
Group type: EXPERIMENTAL
Intervention: Seeking Safety (SS)
Number of subjects: 353